TR200100363T2 - Vitronektin reseptör antagonistleri. - Google Patents

Vitronektin reseptör antagonistleri.

Info

Publication number
TR200100363T2
TR200100363T2 TR2001/00363T TR200100363T TR200100363T2 TR 200100363 T2 TR200100363 T2 TR 200100363T2 TR 2001/00363 T TR2001/00363 T TR 2001/00363T TR 200100363 T TR200100363 T TR 200100363T TR 200100363 T2 TR200100363 T2 TR 200100363T2
Authority
TR
Turkey
Prior art keywords
vitronectin receptor
receptor antagonists
restenosis
osteoporosis
atherosclerosis
Prior art date
Application number
TR2001/00363T
Other languages
English (en)
Inventor
J. Manley Peter
H. Miller William
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200100363T2 publication Critical patent/TR200100363T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Bu bulus, vitronektin reseptörünü önleyen ve ilitihap, kanser ve aterosikleroz ve restenoz gibi kardiyovasküler rahatsizliklar ile osteoporoz gibi, kemik resorpsiyonunun bir faktör oldugu hastaliklarin tedavisinde faydali olan farmasötik olarak aktif bilesikler ile ilgilidir.
TR2001/00363T 1998-08-07 1999-08-03 Vitronektin reseptör antagonistleri. TR200100363T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9570398P 1998-08-07 1998-08-07

Publications (1)

Publication Number Publication Date
TR200100363T2 true TR200100363T2 (tr) 2001-06-21

Family

ID=22253229

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00363T TR200100363T2 (tr) 1998-08-07 1999-08-03 Vitronektin reseptör antagonistleri.

Country Status (18)

Country Link
US (1) US6458814B1 (tr)
EP (1) EP1102587A4 (tr)
JP (1) JP2002522360A (tr)
KR (1) KR20010086355A (tr)
CN (1) CN1322133A (tr)
AR (1) AR020121A1 (tr)
AU (1) AU5336299A (tr)
BR (1) BR9912638A (tr)
CA (1) CA2339666A1 (tr)
CO (1) CO5170532A1 (tr)
CZ (1) CZ2001447A3 (tr)
HU (1) HUP0103090A3 (tr)
IL (1) IL141163A0 (tr)
NO (1) NO20010620L (tr)
PL (1) PL346157A1 (tr)
TR (1) TR200100363T2 (tr)
WO (1) WO2000007544A2 (tr)
ZA (1) ZA200100935B (tr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
DE60130910T2 (de) 2000-04-17 2008-07-10 Ucb Pharma, S.A. Enamin-derivate als zell-adhäsionsmoleküle
US7119098B2 (en) 2000-06-15 2006-10-10 Pharmacia Corporation Heteroarylakanoic acids as intergrin receptor antagonists
FR2847254B1 (fr) * 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
JP2006516144A (ja) 2002-12-20 2006-06-22 ファルマシア・コーポレーション インテグリン受容体アンタゴニスト誘導体としてのチアゾール化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59108771A (ja) * 1982-12-13 1984-06-23 Taiho Yakuhin Kogyo Kk オキサゾール誘導体
FI922867A7 (fi) * 1991-06-21 1992-12-22 Tanabe Seiyaku Co Dikarbonsyraderivat och foerfarande foer framstaellning av dem
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
NZ290008A (en) * 1994-06-29 1998-08-26 Smithkline Beecham Corp Vitronectin receptor antagonists, comprising a fibrinogen antagonist analogue linked to a heterocycle

Also Published As

Publication number Publication date
ZA200100935B (en) 2002-05-14
CN1322133A (zh) 2001-11-14
EP1102587A4 (en) 2003-03-12
WO2000007544A3 (en) 2000-05-18
BR9912638A (pt) 2001-05-02
US6458814B1 (en) 2002-10-01
WO2000007544A2 (en) 2000-02-17
KR20010086355A (ko) 2001-09-10
NO20010620D0 (no) 2001-02-06
HUP0103090A3 (en) 2002-12-28
HUP0103090A2 (hu) 2002-01-28
CO5170532A1 (es) 2002-06-27
NO20010620L (no) 2001-02-06
AU5336299A (en) 2000-02-28
EP1102587A2 (en) 2001-05-30
JP2002522360A (ja) 2002-07-23
CA2339666A1 (en) 2000-02-17
AR020121A1 (es) 2002-04-10
PL346157A1 (en) 2002-01-28
IL141163A0 (en) 2002-02-10
CZ2001447A3 (cs) 2001-08-15

Similar Documents

Publication Publication Date Title
TR199801253T2 (tr) Vitronektin reseptörü antagonistleri.
TR199801255T2 (tr) Vitronektin reseptör antagonistleri.
SE9901272D0 (sv) New improved formulation
IL142066A0 (en) Arylsulfonanilide urea derivatives and pharmaceutical compositions containing the same
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
TR200101858T2 (tr) JNK protein kinaz inhibitörleri olarak 4-ariloksindoller
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
TR200103431T2 (tr) Alfa V integrin reseptör antagonistleri.
TR200101895T2 (tr) Cinsel rahatsızlıkların tedavisi.
DK0889886T3 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR200002625T2 (tr) Vitronektin Reseptörü Antagonistleri
DE69720062D1 (de) Integrin antagonisten
TR200100462T2 (tr) Muskarinik agonistleri ve antagonistleri
TR200200066T2 (tr) Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri
TR200101756T2 (tr) Protein kinaz inhibitörleri olarak 4,5-pirazinoksindoller.
TR200200359T2 (tr) Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması
CY1106444T1 (el) 17b-νιτρο-11β-αρυλοστepοειδη και παραγωγα αυτων ως ορμονικοι αγωνιστες ή ανταγωνιστες
TR200000792T2 (tr) Vitronektin reseptör antagonistleri.
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
TR200100363T2 (tr) Vitronektin reseptör antagonistleri.
TR200102448T2 (tr) COPD tedavisi için kontrollu salma formülasyonu.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
AP9801202A0 (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
DE69911017D1 (en) Arylsulfonanilid-phosphate
DE69831737D1 (de) Neurotrypsin